Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study - Concepedia

Concepedia

Publication | Open Access

Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study

DOI Full Paper Access

10

Citations

8

References

2022

Year

Li Li, Yufeng Li, Yunhua Bai, Guohua Li, Jing Zhang, Liqing Yang, Weimin Zhao, Wei Zhao, Fengji Luo, Qin‐Hua Zhao,

Abstract

ClinicalTrials.gov #NCT02559921.

References

	Year	Citations

Page 1